Injectable hyaluronic acid (HA) fillers are flooding the market, challenging aesthetic physicians to determine which product is best for an individual patient’s soft-tissue volume loss or facial rejuvenation needs.
It's not so easy. Clinical data looking at product performance is lacking, according to authors of a recent paper published April 2019 in Plastic and Reconstructive Surgery.
Read more at Dermatology Times >>